vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and VisionWave Holdings, Inc. (VWAV). Click either name above to swap in a different company.

CVRx, Inc. is the larger business by last-quarter revenue ($16.0M vs $10.0M, roughly 1.6× VisionWave Holdings, Inc.). VisionWave Holdings, Inc. runs the higher net margin — -69.4% vs -74.5%, a 5.1% gap on every dollar of revenue.

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

CoMix Wave Films, Inc. is a Japanese independent animation film studio and distribution company based in Chiyoda, Tokyo, Japan. The studio is known for its anime feature films, short films, and television commercials, particularly those made by director Makoto Shinkai. It was founded in March 2007 when it split from CoMix Wave Inc., which was initially formed in 1998 from Itochu Corporation, ASATSU, and other companies. On 15 October 2024, Toho announced that they'd acquired 45 shares or 6.0...

CVRX vs VWAV — Head-to-Head

Bigger by revenue
CVRX
CVRX
1.6× larger
CVRX
$16.0M
$10.0M
VWAV
Higher net margin
VWAV
VWAV
5.1% more per $
VWAV
-69.4%
-74.5%
CVRX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CVRX
CVRX
VWAV
VWAV
Revenue
$16.0M
$10.0M
Net Profit
$-11.9M
$-6.9M
Gross Margin
86.3%
Operating Margin
-69.8%
-65.7%
Net Margin
-74.5%
-69.4%
Revenue YoY
4.4%
Net Profit YoY
-12.0%
-1522.6%
EPS (diluted)
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
VWAV
VWAV
Q4 25
$16.0M
$10.0M
Q3 25
$14.7M
Q2 25
$13.6M
Q1 25
$12.3M
Q4 24
$15.3M
Q3 24
$13.4M
Q2 24
$11.8M
Q1 24
$10.8M
Net Profit
CVRX
CVRX
VWAV
VWAV
Q4 25
$-11.9M
$-6.9M
Q3 25
$-12.9M
Q2 25
$-14.7M
Q1 25
$-13.8M
Q4 24
$-10.7M
Q3 24
$-13.1M
Q2 24
$-14.0M
Q1 24
$-22.2M
Gross Margin
CVRX
CVRX
VWAV
VWAV
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
Q1 24
85.0%
Operating Margin
CVRX
CVRX
VWAV
VWAV
Q4 25
-69.8%
-65.7%
Q3 25
-83.5%
Q2 25
-105.8%
Q1 25
-108.8%
Q4 24
-67.0%
Q3 24
-97.3%
Q2 24
-118.3%
Q1 24
-206.4%
Net Margin
CVRX
CVRX
VWAV
VWAV
Q4 25
-74.5%
-69.4%
Q3 25
-87.6%
Q2 25
-108.4%
Q1 25
-111.5%
Q4 24
-69.4%
Q3 24
-98.0%
Q2 24
-118.8%
Q1 24
-206.0%
EPS (diluted)
CVRX
CVRX
VWAV
VWAV
Q4 25
$-0.45
Q3 25
$-0.49
Q2 25
$-0.57
Q1 25
$-0.53
Q4 24
$-0.39
Q3 24
$-0.57
Q2 24
$-0.65
Q1 24
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
VWAV
VWAV
Cash + ST InvestmentsLiquidity on hand
$75.7M
$15.7K
Total DebtLower is stronger
Stockholders' EquityBook value
$39.3M
$3.1M
Total Assets
$104.8M
$18.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
VWAV
VWAV
Q4 25
$75.7M
$15.7K
Q3 25
$85.1M
Q2 25
$95.0M
Q1 25
$102.7M
Q4 24
$105.9M
Q3 24
$100.2M
Q2 24
$70.4M
Q1 24
$80.1M
Stockholders' Equity
CVRX
CVRX
VWAV
VWAV
Q4 25
$39.3M
$3.1M
Q3 25
$48.1M
Q2 25
$57.9M
Q1 25
$71.1M
Q4 24
$71.1M
Q3 24
$65.2M
Q2 24
$55.2M
Q1 24
$66.3M
Total Assets
CVRX
CVRX
VWAV
VWAV
Q4 25
$104.8M
$18.4M
Q3 25
$111.3M
Q2 25
$119.6M
Q1 25
$129.6M
Q4 24
$133.4M
Q3 24
$127.7M
Q2 24
$96.0M
Q1 24
$106.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
VWAV
VWAV
Operating Cash FlowLast quarter
$-9.8M
$-5.4M
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-61.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
VWAV
VWAV
Q4 25
$-9.8M
$-5.4M
Q3 25
$-9.7M
Q2 25
$-7.9M
Q1 25
$-12.8M
Q4 24
$-8.0M
Q3 24
$-10.4M
Q2 24
$-9.8M
Q1 24
$-10.9M
Free Cash Flow
CVRX
CVRX
VWAV
VWAV
Q4 25
$-9.8M
Q3 25
$-10.0M
Q2 25
$-8.0M
Q1 25
$-12.9M
Q4 24
$-8.1M
Q3 24
$-10.4M
Q2 24
$-10.2M
Q1 24
$-11.8M
FCF Margin
CVRX
CVRX
VWAV
VWAV
Q4 25
-61.3%
Q3 25
-68.1%
Q2 25
-59.2%
Q1 25
-104.3%
Q4 24
-52.5%
Q3 24
-78.1%
Q2 24
-86.3%
Q1 24
-109.7%
Capex Intensity
CVRX
CVRX
VWAV
VWAV
Q4 25
0.4%
Q3 25
2.0%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
3.0%
Q1 24
8.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

VWAV
VWAV

Segment breakdown not available.

Related Comparisons